Skip to main content
404 (Not Found)
The webpage you are looking for is unavailable.
The URL may have been incorrectly typed or the page may have been moved, deleted, or incorporated into another part of the website.

Important Safety Information 

AFINITOR and AFINITOR DISPERZ are contraindicated in patients with hypersensitivity to everolimus, to other rapamycin derivatives, or to any of the excipients...

Indications

Advanced HR+, HER2-Negative Breast Cancer

AFINITOR is indicated for the treatment of postmenopausal women with advanced hormone receptor-positive, HER2-negative breast cancer in combination with exemestane after failure of treatment with letrozole or anastrozole...

Click or scroll to see IMPORTANT SAFETY INFORMATION AND INDICATIONS